Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Aug-23 4:09 PM View:  | Vertex Pharmaceuticals Inc. (VRTX) | 10-Aug-23 | Option Exercise | 10,000 | $127.54 | $1,275,400.00 | 153% 6.54K to 16.54K | |
| 14-Aug-23 4:09 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Aug-23 | Planned Option Sale | 10,000 | $350.00 | $3,500,000.00 | (60%) 16.54K to 6.54K | |
| 03-May-22 5:41 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-May-22 | Grant | 725 | -- | -- | 12% 5.81K to 6.54K | |
| 22-Nov-21 9:08 AM View: | Acceleron Pharma Inc (XLRN) | 19-Nov-21 | Disposition (change in control) | 6,749 | -- | -- | (100%) 6.75K to 0 | |
| 02-Feb-21 6:41 PM View: | Acceleron Pharma Inc (XLRN) | 29-Jan-21 | Grant | 1,622 | -- | -- | 32% 5.13K to 6.75K | |
| 13-Oct-20 7:14 PM View: | Acceleron Pharma Inc (XLRN) | 12-Oct-20 | Option Exercise | 37,500 | $28.62 | $1,073,380.00 | 731% 5.13K to 42.63K | |
| 13-Oct-20 7:14 PM View: | Acceleron Pharma Inc (XLRN) | 12-Oct-20 | Market Option Sale (Planned) | 37,500 | $119.36 | $4,475,980.00 | (88%) 42.63K to 5.13K | (51%) |
| 24-Jan-20 5:45 PM View: | Acceleron Pharma Inc (XLRN) | 22-Jan-20 | Grant | 1,377 | -- | -- | 37% 3.75K to 5.13K | |
| 04-Nov-19 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Nov-19 | Option Exercise | 47,448 | $79.17 | $3,756,370.00 | 529% 8.97K to 56.42K | |
| 04-Nov-19 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Nov-19 | Planned Option Sale | 45,607 | $200.00 | $9,121,400.00 | (81%) 56.42K to 10.81K | |
| 04-Nov-19 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Nov-19 | Sale (Planned) | 5,000 | $200.00 | $1,000,000.00 | (46%) 10.81K to 5.81K | |
| 04-Nov-19 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-Oct-19 | Planned Private Option Sale | 1,841 | $200.00 | $368,200.00 | (17%) 10.81K to 8.97K | |
| 04-Jun-19 4:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Jun-19 | Grant | 2,381 | -- | -- | 28% 8.43K to 10.81K | |
| 29-Jan-19 5:46 PM View: | Acceleron Pharma Inc (XLRN) | 25-Jan-19 | Grant | 1,250 | -- | -- | 50% 2.5K to 3.75K | |
| 05-Jun-18 4:58 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Jun-18 | Grant | 1,801 | -- | -- | 27% 6.63K to 8.43K | |
| 15-May-18 12:32 PM View: | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 1,106 | -- | -- | (100%) 1.11K to 0 | |
| 30-Mar-18 5:54 PM View: | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 1,106 | -- | -- | 100% 0 to 1.11K | |
| 05-Mar-18 5:20 PM View: | Acceleron Pharma Inc (XLRN) | 01-Mar-18 | Grant | 1,250 | -- | -- | 100% 1.25K to 2.5K | |
| 05-Jun-17 5:11 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Jun-17 | Grant | 2,188 | -- | -- | 49% 4.44K to 6.63K | |
| 14-Mar-17 6:20 PM View: | Acceleron Pharma Inc (XLRN) | 02-Mar-17 | Grant | 1,250 | -- | -- | 100% 0 to 1.25K | |
| 03-Jun-16 5:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Jun-16 | Grant | 2,941 | $0.01 | $29.41 | 196% 1.5K to 4.44K | |
| 21-May-15 4:16 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 19-May-15 | Option Exercise | 1,500 | $56.99 | $85,485.00 | 100% 0 to 1.5K | |
| 29-Apr-15 8:34 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 27-Apr-15 | Option Exercise | 68,125 | $56.82 | $3,870,840.00 | 100% 0 to 68.13K | |
| 29-Apr-15 8:34 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 27-Apr-15 | Market Option Sale (Planned) | 68,125 | $129.10 | $8,795,290.00 | (100%) 68.13K to 0 | (35%) |
| 27-Apr-15 6:31 PM View: | Theravance Inc. (INVA) | 24-Apr-15 | Grant | 13,950 | -- | -- | 60% 23.13K to 37.08K | |
| 03-Nov-14 4:45 PM View: | Theravance Inc. (INVA) | 30-Oct-14 | Grant | 23,133 | -- | -- | 100% 0 to 23.13K | |
| 17-Dec-10 3:02 PM View: | Hospira Inc. (HSP) | 16-Dec-10 | Market Sale (Planned) | 74,643 | $57.00 | $4,254,650.00 | (59%) 125.87K to 51.23K | (52%) |
| 17-Dec-10 3:02 PM View: | Hospira Inc. (HSP) | 15-Dec-10 | Option Exercise | 70,000 | $32.47 | $2,272,900.00 | 43% 161.23K to 231.23K | |
| 17-Dec-10 3:02 PM View: | Hospira Inc. (HSP) | 15-Dec-10 | Market Option Sale (Planned) | 70,000 | $57.02 | $3,991,540.00 | (30%) 231.23K to 161.23K | (52%) |
| 17-Dec-10 3:02 PM View: | Hospira Inc. (HSP) | 15-Dec-10 | Market Sale (Planned) | 35,357 | $57.02 | $2,016,130.00 | (22%) 161.23K to 125.87K | (52%) |
| 25-Oct-10 10:32 AM View: | Hospira Inc. (HSP) | 21-Oct-10 | Payment of Exercise | 47,407 | $58.01 | $2,750,080.00 | (20%) 237.94K to 190.53K | (49%) |
| 25-Oct-10 10:32 AM View: | Hospira Inc. (HSP) | 21-Oct-10 | Option Exercise | 83,384 | $49.68 | $4,142,330.00 | 54% 154.56K to 237.94K | |
| 25-Oct-10 10:32 AM View: | Hospira Inc. (HSP) | 21-Oct-10 | Market Option Sale (Planned) | 29,306 | $59.00 | $1,729,050.00 | (15%) 190.53K to 161.23K | (47%) |
| 29-Sep-10 4:47 PM View: | Hospira Inc. (HSP) | 27-Sep-10 | Option Exercise | 136,097 | $25.89 | $3,523,120.00 | 124% 109.79K to 245.89K | |
| 29-Sep-10 4:47 PM View: | Hospira Inc. (HSP) | 27-Sep-10 | Market Option Sale (Planned) | 91,334 | $57.00 | $5,206,040.00 | (37%) 245.89K to 154.56K | (52%) |
| 23-Sep-10 10:41 AM View: | Hospira Inc. (HSP) | 21-Sep-10 | Payment of Exercise | 8,777 | $56.26 | $493,794.00 | (7%) 118.57K to 109.79K | (54%) |
| 23-Sep-10 10:41 AM View: | Hospira Inc. (HSP) | 21-Sep-10 | Option Exercise | 10,004 | $44.87 | $448,879.00 | 9% 108.57K to 118.57K | |
| 17-Sep-10 3:14 PM View: | Hospira Inc. (HSP) | 16-Sep-10 | Payment of Exercise | 5,928 | $55.45 | $328,708.00 | (5%) 114.5K to 108.57K | (56%) |
| 17-Sep-10 3:14 PM View: | Hospira Inc. (HSP) | 16-Sep-10 | Option Exercise | 6,781 | $43.93 | $297,889.00 | 6% 107.71K to 114.5K | |
| 22-Apr-10 3:48 PM View: | Hospira Inc. (HSP) | 20-Apr-10 | Payment of Exercise | 81,207 | $55.57 | $4,512,670.00 | (43%) 188.92K to 107.71K | (56%) |
| 22-Apr-10 3:48 PM View: | Hospira Inc. (HSP) | 20-Apr-10 | Option Exercise | 94,954 | $42.28 | $4,014,990.00 | 101% 93.97K to 188.92K | |
| 31-Mar-10 2:49 PM View: | Hospira Inc. (HSP) | 30-Mar-10 | Payment of Exercise | 12,354 | $56.86 | $702,448.00 | (12%) 106.32K to 93.97K | (52%) |
| 31-Mar-10 2:49 PM View: | Hospira Inc. (HSP) | 30-Mar-10 | Option Exercise | 15,212 | $39.22 | $596,615.00 | 17% 91.11K to 106.32K | |
| 22-Feb-10 3:34 PM View: | Hospira Inc. (HSP) | 19-Feb-10 | Payment of Exercise | 3,947 | $51.81 | $204,494.00 | (4%) 95.06K to 91.11K | (67%) |
| 22-Feb-10 3:34 PM View: | Hospira Inc. (HSP) | 19-Feb-10 | Option Exercise | 4,579 | $39.22 | $179,588.00 | 5% 90.48K to 95.06K | |
| 06-Nov-09 1:59 PM View: | Hospira Inc. (HSP) | 05-Nov-09 | Option Exercise | 2,281 | $43.80 | $99,907.80 | 3% 90.48K to 92.76K | 98% |
| 06-Nov-09 1:59 PM View: | Hospira Inc. (HSP) | 05-Nov-09 | Market Option Sale | 2,281 | $46.00 | $104,926.00 | (2%) 92.76K to 90.48K | (88%) |
| 21-Oct-09 12:14 PM View: | Hospira Inc. (HSP) | 19-Oct-09 | Payment of Exercise | 69,186 | $46.19 | $3,195,700.00 | (43%) 159.66K to 90.48K | (88%) |
| 21-Oct-09 12:14 PM View: | Hospira Inc. (HSP) | 19-Oct-09 | Option Exercise | 79,028 | $36.90 | $2,915,830.00 | 98% 80.64K to 159.66K | |
| 01-Oct-09 3:49 PM View: | Hospira Inc. (HSP) | 29-Sep-09 | Payment of Exercise | 10,004 | $44.87 | $448,879.00 | (11%) 90.64K to 80.64K | (93%) |